Showing results (221-230 of 298) with videos related to
Sort By:
Pageof 30
Journal of Cardiovascular Pharmacology|March 10, 2000
Pharmacologic profile of UR-7247, an orally active angiotensin II AT1 receptor antagonist, in healthy volunteers. p6M P Maillard, J Rossat, J Nussberger, et al.Ophthalmology|December 22, 1999
Orbital infarction and melting in a patient with systemic lupus erythematosusB P Arthurs, M K Khalil, F Chagnon, et al.Journal of Hypertension|July 1, 1995
Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertensionB Favrat, M Burnier, J Nussberger, et al.Journal of Clinical Pharmacology|August 1, 1997
Sinistrin clearance for determination of glomerular filtration rate: a reappraisal of various approaches using a new analytical methodT Buclin, A Pechère-Bertschi, R Séchaud, et al.Administration in Social Work|December 10, 1990
Organizational affiliation and effectiveness: the case of rape crisis centersD B Byington, P Y Martin, D M DiNitto, et al.Revue Medicale Suisse|April 12, 2008
[Nephrogenic systemic fibrosis: another problem for patients with chronic renal failure]P-R Michelet, C Stoermann Chopard, P-Y Martin, et al.Medicine and Law|January 1, 1989
Rape treatment programmes: delivering innovative services to survivorsD M DiNotto, P Y Martin, M S Maxwell, et al.Journal of Cardiovascular Pharmacology|February 1, 1990
Reactive hyperreninemia is a major determinant of plasma angiotensin II during ACE inhibitionV Mooser, J Nussberger, L Juillerat, et al.Peptides|January 1, 1994
Localization of neuropeptide Y and its C-terminal flanking peptide in human renal tissueE Grouzmann, G Alvarez-Bolado, C Meyer, et al.International Journal of Clinical Practice|November 25, 2010
Effects on blood pressure and cardiovascular risk of variations in patients' adherence to prescribed antihypertensive drugs: role of duration of drug actionA Lowy, V C Munk, S H Ong, et al.Pageof 30